Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Digital Transformation

Set Alert for Digital Transformation

Novo Nordisk Looks To Bring AI/ML To Cardiometabolic Disease In Valo Health Deal

Deal Snapshot: The Danish drug maker plans to pay up to $2.7bn to Flagship Pioneering-incubated Valo Health for its AI-enabled small molecule discovery and human genetic data platform.

Artificial Intelligence Deals

BenevolentAI Still Bullish As CEO Shields Steps Down

BenevolentAI has added Merck KGaA to its list of partners but the UK firm is looking for a new CEO after Joanna Shields decided to leave as a major restructuring continues.

Artificial Intelligence Business Strategies

Eisai Digital Venture Theoria Plans Dementia Data Insights

A new digital health venture set up by Eisai plans to start operations in Japan from April 2024 with services related to cognitive impairment and dementia, in line with the Japanese firm's therapeutic advances in this area.

Japan Digital Health

First Wave Rises With Sanofi GI Deal

First Wave is licensing Sanofi’s 5-HT4 receptor partial agonist capeserod and is having to pay a mere $500,000 in upfront fees for the privilege.

Deals Gastrointestinal

AI-Fueled Generate Maps Out Path To Clinic Over Next 24 Months

The biotech company already has a candidate with a tough target in the clinic for COVID-19 and plans to have four to six candidates in the clinic over the next two years following a $273m series C round.

Artificial Intelligence Financing

Verge Builds Out Big Pharma AI Partnerships With AstraZeneca Deal

Deal Snapshot: Two years into a three-year partnership with Lilly, Verge announced another deal, with AstraZeneca’s Alexion, just months after acquiring bragging rights with early clinical data for an AI-discovered product candidate.

Deals Artificial Intelligence

Dr Reddy’s MD On The Next Horizon, Owner-Managed Firms, 'Birds And Beliefs'

Dr Reddy's Laboratories' co-chairman and MD, GV Prasad, talks about his conversations with late founder Dr Anji Reddy, the company’s ‘Horizon 2’ strategy, pricing expectations for CAR-T cell therapies, the promise of the China market, how Indian owner-managed pharma firms are figuring out ways to deal with succession aspects and his new book.

Commercial Strategy

Quick Listen: Scrip's Five Must-Know Things

In this week's podcast edition of Five Must-Know Things: Wegovy’s solid new trial results; Lilly’s sales swing back; nothing off the table for new Bayer boss; new compliance crackdown in China; and McKinsey on AI.

Commercial Sales & Earnings

'Evergreen' Cipla: Chair Hamied Talks New Technologies Amid 'Speculative' Sale News

Cipla’s chief Dr Yusuf Hamied talks about investments in new technologies that will shape the company’s future, terming reports of a stake sale as “speculative" but not going as far as an outright denial.

Commercial Respiratory

McKinsey Exec On Generative AI in R&D And Pharmacovigilance, Digital Twins

McKinsey & Company's senior partner Vikas Bhadoria, in this first instalment of a wide-ranging two-part interview with Scrip, outlines a number of use cases to define where pharma currently is and the potential value that can be unlocked as industry adopts new technologies such as generative AI, digital twins and the metaverse.

Commercial Artificial Intelligence

Indian ‘Lighthouses’ Deliver Gains Amid Price Erosion, Rising Input Costs

Senior executives from Dr Reddy’s and Cipla showcase the “step-change” in performance across cost, quality and delivery metrics at their ‘lighthouse’ manufacturing sites in India as industry tackles dwindling operating margins and evolving compliance requirements. 

Commercial Manufacturing

Patient Voice To Data: How Novartis Is Listening Up, Harnessing RWE In APMA

Physician-turned-pharma executive, Iris Zemzoum, leads Novartis in the Asia Pacific, Middle East and Africa (APMA) region. She tells Scrip how the Swiss group is empowering patients to help shape the future of healthcare and also partnering across the diverse region to leverage real-world evidence.

Commercial Asia Pacific

Quick Listen: Scrip's Five Must-Know Things

In this week's podcast edition of Five Must-Know Things: Merck & Co takes IRA legal action; notes from BIO Day 1; stories from ASCO around ImmunoGen’s ovarian cancer candidate and Servier’s progress in glioma; and the future of AI in pharma.

Legal Issues Clinical Trials

ChatGPT Unleashed: Generative AI Use Cases Taking Off In Pharma

As generative AI and its star avatar, ChatGPT, take the world by storm, pharma is seeing traction for use cases around smarter pharmacovigilance and commercial marketing content development, among others. Senior executives from Indegene discuss this and more in an interview with Scrip.

Commercial Artificial Intelligence

Dr Reddy’s CEO: We’re In ‘Great Dialogue’ With The Innovation Industry In China

Dr Reddy’s is collaborating with innovator firms in China, Israel and the US largely in areas of unmet need, propelling its “Horizon-2” strategy that encompasses segments like biologics and cell and gene therapy, digital services and immuno-oncology NCEs, among others.

Commercial Deals

BenevolentAI Slashes Jobs And Drug Programs

The UK firm, which uses artificial intelligence to discover and develop drugs, is hoping to save £45m by halving its workforce and trimming its pipeline.

Restructuring Artificial Intelligence
See All
UsernamePublicRestriction

Register